Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coagadex in Acquired Factor X Deficiency Associated With AL Amyloidosis
NCT06963216Phase 3Withdrawn
- Sponsor
- Kedrion Biopharma
- Start
- Jun 2026
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of human coagulation factor X in acquired factor X deficiency, sponsored by Kedrion Biopharma. Planned start Jun 2026; status: withdrawn.
02
Drugs
human coagulation factor X
03
Conditions
acquired factor X deficiency
Beyond the preview
Go deeper on NCT06963216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06963216.